MUNICH, June 16, 2026 /PRNewswire/ -- Innovative Molecules GmbH ("IM"), a clinical-stage biopharmaceutical company focused on herpesvirus-mediated diseases, today announced the advancement of its virology pipeline with the addition of a novel Epstein-Barr Virus (EBV) antiviral program....
Hence then, the article about innovative molecules expands virology pipeline with novel ebv antiviral program was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Innovative Molecules Expands Virology Pipeline with Novel EBV Antiviral Program )
Also on site :
- Dodgers To Activate Tommy Edman On Tuesday
- Hundreds of Stanford students walked out of their grad ceremony to protest Google CEO’s commencement speech. It wasn’t all about AI
- Cape Verde Goalkeeper Gains Over 2 Million Instagram Followers After Heroic World Cup Performance in Draw Against Spain